The deletion of these transcription factors or mutations in the binding sites of these transcription factors result in a reduced expression of the FXN gene, while overexpressing SRF and TFAP2 increases the FXN mRNA levels in both cell lines and FRDA patient lymphoblasts [20]. This evidence concerns the gene SRF and Friedreich ataxia.